— Know what they know.
Not Investment Advice

NDTP OTC

NDT Pharmaceuticals Inc.
1W: -35.9% 1M: -39.2% 3M: -44.5% YTD: -84.0% 1Y: -78.2% 3Y: -94.8% 5Y: +121328.6%
$0.26
+0.01 (+2.00%)
 
Weekly Expected Move ±23.8%
$0 $0 $0 $0 $0
OTC · Healthcare · Biotechnology · Tech Score Strong Sell · Power 36 · $40.8M mcap · 56M float · 0.0046% daily turnover · Short 41% of daily vol
Smart Money Score
No convergence signal
Key Statistics
Market Cap$40.8M
52W Range0.243-2.1
Volume681
Avg Volume2,575
Beta0.00
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOJames Hovis
SectorHealthcare
IndustryBiotechnology
IPO Date2008-01-22
8400 Old Courthouse Road
Vienna, VA 22182
US
402-676-9010
About NDT Pharmaceuticals Inc.

NDT Pharmaceuticals Inc., a biotechnology firm situated in Vienna, Virginia, is dedicated to formulating a range of treatments for serious neurological ailments, particularly those stemming from traumatic brain injuries.

Recent Insider Trades

NameTypeSharesPriceDate
CARASQUERO FRANCISCO G-Gift 96,000 $0.00 2007-03-29
CARASQUERO FRANCISCO 0 — 2007-03-28
CARASQUERO FRANCISCO 0 — 2007-03-28
XINOS JOHN ANASTASIO 0 — 2006-06-02

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms